8-K: HealthEquity Reports Record Q3 FY26 Results

HealthEquity, a leader in health savings accounts, announced record third-quarter fiscal 2026 financial results, driven by strong revenue growth and significant increases in net income and Adjusted EBITDA.

Summary

• Revenue increased 7% year-over-year to $322.2 million for the third quarter ended October 31, 2025.
• Net income per diluted share (GAAP) rose significantly to $0.59, up from $0.06 in the prior year quarter.
• Non-GAAP net income per diluted share increased 29% to $1.01, compared to $0.78 in the same period last year.
• Adjusted EBITDA grew 20% year-over-year to $141.8 million, representing 44% of revenue, up from 39% in the prior year.
• Total HSA Assets increased 15% year-over-year to $34.4 billion as of October 31, 2025.
• The company repurchased 1.0 million shares of its common stock for $93.7 million during the third quarter.
• HSA cash repricing risk was further reduced with a cumulative $2.25 billion 5-year Treasury bond hedge at 3.94%.

Sentiment

Score: 9

Explanation: The company reported exceptionally strong financial results across key metrics, including significant increases in revenue, net income, and Adjusted EBITDA, coupled with robust growth in HSA assets and accounts. The positive outlook for the full fiscal year further reinforces a very strong performance.

Positives

• Revenue increased 7% to $322.2 million, demonstrating consistent top-line growth.
• GAAP net income per diluted share surged to $0.59 from $0.06, indicating a substantial improvement in profitability.
• Non-GAAP net income per diluted share grew 29% to $1.01, reflecting strong operational performance.
• Adjusted EBITDA increased 20% to $141.8 million, with the Adjusted EBITDA margin expanding to 44% of revenue from 39% year-over-year.
• Total HSA Assets grew 15% to $34.4 billion, highlighting robust asset accumulation.
• The number of HSAs increased 6% year-over-year to 10.1 million, and HSAs with investments grew 12% to 802,000.
• The company returned $93.7 million to shareholders through stock repurchases, demonstrating commitment to shareholder value.
• HSA cash repricing risk was strategically reduced with a $2.25 billion 5-year Treasury bond hedge at 3.94%.

Negatives

• New HSAs from sales decreased 6% quarter-to-date (175,000 vs. 186,000 in Q3 FY25).
• New HSAs from sales decreased 14% year-to-date (487,000 vs. 568,000 in the first nine months of FY25).

Risks

• Ability to adequately place and safeguard custodial assets, or the failure of any depository or insurance company partners.
• Ability to compete effectively in a rapidly evolving healthcare and benefits administration industry.
• Dependence on the continued availability and benefits of tax-advantaged HSAs and other consumer-directed benefits (CDBs).
• Impact of recent fraudulent account activity involving member accounts or third-party service providers on reputation and financial results.
• Ability to successfully identify, acquire, and integrate additional portfolio purchases or acquisition targets.
• Significant competition faced and may face in the future, including from those with greater resources.
• Reliance on the availability and performance of technology and communications systems.
• Impact of cybersecurity breaches of technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage, and loss of business.
• The current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations.
• Ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser, and other laws applicable to the business.
• Reliance on partners and third-party vendors for distribution and important services.
• Ability to develop and implement updated features for technology platforms and communications systems.
• Reliance on the management team and key team members.

Future Outlook

For the fiscal year ending January 31, 2026, management expects revenues between $1.302 billion and $1.312 billion. Net income is projected to be between $197 million and $205 million, resulting in GAAP net income per diluted share of $2.24 to $2.33. Non-GAAP net income is anticipated to be between $341 million and $348 million, leading to non-GAAP net income per diluted share of $3.87 to $3.95. Adjusted EBITDA is expected to range from $555 million to $565 million.

Management Comments

• "HealthEquity delivered a record third quarter for fiscal 2026, with net income of $52 million, 20% growth in Adjusted EBITDA, and 29% growth in non-GAAP net income per share, reflecting our teams focus on helping members better save, spend and invest for health." Scott Cutler, President and CEO of HealthEquity.
• "Our marketplace platform is expanding access to more affordable healthcare solutions, and AI is beginning to power more personalized and efficient experiences. As we enter onboarding season, we do so with strong momentum and an enduring mission to save and improve lives by empowering healthcare consumers." Scott Cutler, President and CEO of HealthEquity.

Industry Context

HealthEquity operates in the dynamic U.S. healthcare finance sector, specializing in Health Savings Accounts (HSAs) and other Consumer-Directed Benefits (CDBs). The strong growth in HSA assets and accounts reflects a broader trend of increasing consumer responsibility for healthcare costs and the appeal of tax-advantaged savings vehicles. The company's emphasis on expanding its marketplace platform and integrating AI for personalized experiences aligns with industry-wide digital transformation and customer-centric strategies aimed at improving efficiency and user engagement in financial and healthcare services.

Comparison to Industry Standards

• The 15% year-over-year growth in Total HSA Assets to $34.4 billion demonstrates robust asset gathering capabilities, potentially outpacing some competitors in the fragmented HSA market.
• The expansion of Adjusted EBITDA margin from 39% to 44% suggests improved operational efficiency and cost management, which is a strong indicator of competitive advantage in the benefits administration industry.
• The significant increase in GAAP net income per diluted share from $0.06 to $0.59 indicates superior profitability growth compared to many mature financial services or healthcare administration companies.
• The strategic use of a $2.25 billion 5-year Treasury bond hedge at 3.94% to mitigate HSA cash repricing risk highlights proactive financial management, a practice that sets a high standard for risk mitigation in custodial services.

Stakeholder Impact

• Shareholders are positively impacted by strong financial performance, increased profitability, and the ongoing stock repurchase program, which returned $93.7 million in Q3 and has $258.8 million remaining authorization.
• Customers (HSA members) benefit from continued growth in HSA assets and accounts, along with the company's focus on expanding its marketplace platform and integrating AI for more personalized and efficient experiences.
• Employees are likely to experience positive impacts due to the company's strong performance, which typically indicates stability and potential for growth opportunities.
• Partners and third-party vendors may see stable or increasing engagement due to HealthEquity's continued business growth and market expansion.

Next Steps

• HealthEquity management will host a conference call on December 3, 2025, at 4:30 pm (Eastern Time) to discuss the fiscal 2026 third-quarter financial results.

Key Dates

Recommendation

HealthEquity delivered exceptional third-quarter results, demonstrating robust growth in revenue, profitability, and key asset metrics. The significant increase in GAAP and non-GAAP net income per diluted share, coupled with strong Adjusted EBITDA growth and margin expansion, indicates excellent operational execution. The company's continued growth in HSA assets and accounts, along with strategic risk mitigation through bond hedges and a substantial stock repurchase program, underscores a healthy financial position and commitment to shareholder value. The positive full-year outlook further strengthens the investment case, suggesting sustained momentum and potential for continued outperformance in the healthcare finance sector.

Keywords

Health Savings Accounts, HSAs, Consumer-Directed Benefits, CDBs, HealthEquity, HQY, Financial Results, Q3 Earnings, Healthcare Finance, Benefits Administration, Custodial Assets, Stock Repurchase